| Reference |
|---|
Yarkova E, Grigor eva E, Medvedev S, Pavlova S, Zakian S, Malakhova A. IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson's Disease Caused by the GBA1 N370S Mutation. Int J Mol Sci. 2023;25: pubmed publisher |
Yoshimatsu S, Okahara J, Yoshie J, Igarashi Y, Nakajima R, Sanosaka T, et al. Generation of a tyrosine hydroxylase-2A-Cre knockin non-human primate model by homology-directed-repair-biased CRISPR genome editing. Cell Rep Methods. 2023;3:100590 pubmed publisher |
Breitmeyer R, Vogel S, Heider J, Hartmann S, W xfc st R, Keller A, et al. Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction. Commun Biol. 2023;6:472 pubmed publisher |
Triebelhorn J, Cardon I, Kuffner K, Bader S, Jahner T, Meindl K, et al. Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties. Mol Psychiatry. 2022;: pubmed publisher |
Gridina M, Nurislamov A, Minina J, Lopatkina M, Drozdov G, Vasilyev S, et al. Generation of iPS cell line (ICGi040-A) from skin fibroblasts of a patient with ring small supernumerary marker chromosome 4. Stem Cell Res. 2022;61:102740 pubmed publisher |
Gridina M, Shitik E, Lemskaya N, Minina J, Grishchenko I, Dolskiy A, et al. Derivation of iPS cell line (ICGi032-A) from a patient affected with fragile X syndrome. Stem Cell Res. 2021;57:102615 pubmed publisher |
de Souza A, Bressan F, Pieri N, Botigelli R, Revay T, Haddad S, et al. Generation of Primordial Germ Cell-like Cells from iPSCs Derived from Turner Syndrome Patients. Cells. 2021;10: pubmed publisher |
Yoshimatsu S, Edamura K, Yoshii Y, Iguchi A, Kondo H, Shibuya H, et al. Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog. Stem Cell Res. 2021;53:102375 pubmed publisher |
Dementyeva E, Pavlova S, Chernyavsky A, Zakian S. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3. Stem Cell Res. 2021;53:102344 pubmed publisher |
Dementyeva E, Vyatkin Y, Chernyavsky A, Zakian S. Generation of an induced pluripotent stem cell line, ICGi028-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.E510Q mutation in HADHA. Stem Cell Res. 2021;53:102348 pubmed publisher |
Podgurskaya A, Slotvitsky M, Tsvelaya V, Frolova S, Romanova S, Balashov V, et al. Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes. Sci Rep. 2021;11:2336 pubmed publisher |
Khabarova A, Pristyazhnyuk I, Orlova P, Nikitina T, Kashevarova A, Lopatkina M, et al. Generation of iPSC line ICGi024-A from human skin fibroblasts of a patient with ring chromosome 18. Stem Cell Res. 2020;49:102076 pubmed publisher |
Gridina M, Orlova P, Minina J, Shitik E, Lemskaya N, Grishchenko I, et al. Establishment of an induced pluripotent stem cell line (ICGi026-A) from peripheral blood mononuclear cells of a patient with fragile X syndrome. Stem Cell Res. 2020;49:102070 pubmed publisher |
Malankhanova T, Suldina L, Grigor eva E, Medvedev S, Minina J, Morozova K, et al. A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities. J Pers Med. 2020;10: pubmed publisher |
Gridina M, Nikitina T, Orlova P, Minina J, Kashevarova A, Yakovleva Y, et al. Establishment of an induced pluripotent stem cell line (ICGi025-A) from fibroblasts of a patient with 46,XY,r(8)/45,XY,-8 mosaicism. Stem Cell Res. 2020;49:102024 pubmed publisher |
Stock R, Vogel S, Mau Holzmann U, Kriebel M, Wüst R, Fallgatter A, et al. Generation and characterization of human induced pluripotent stem cells lines from four patients diagnosed with schizophrenia and one healthy control. Stem Cell Res. 2020;48:101961 pubmed publisher |
Malakhova A, Grigor eva E, Pavlova S, Malankhanova T, Valetdinova K, Vyatkin Y, et al. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population. Stem Cell Res. 2020;48:101952 pubmed publisher |
Ovechkina V, Maretina M, Egorova A, Baranov V, Kiselev A, Zakian S, et al. Generation of a spinal muscular atrophy type III patient-specific induced pluripotent stem cell line ICGi003-A. Stem Cell Res. 2020;48:101938 pubmed publisher |
Valetdinova K, Maretina M, Vyatkin Y, Perepelkina M, Egorova A, Baranov V, et al. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C. Stem Cell Res. 2020;48:101941 pubmed publisher |
Sasaki Honda M, Kagita A, Jonouchi T, Araki T, Hotta A, Sakurai H. Generation of a transgene-free iPSC line and genetically modified line from a facioscapulohumeral muscular dystrophy type 2 (FSHD2) patient with SMCHD1 p.Lys607Ter mutation. Stem Cell Res. 2020;47:101884 pubmed publisher |
Malakhova A, Grigor eva E, Malankhanova T, Pavlova S, Valetdinova K, Abramycheva N, et al. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease. Stem Cell Res. 2020;44:101743 pubmed publisher |
Nachtigal A, Milenkovic A, Brandl C, Schulz H, Duerr L, Lang G, et al. Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies. Int J Mol Sci. 2020;21: pubmed publisher |
Kumar S, Curran J, Espinosa E, Glahn D, Blangero J. Highly efficient induced pluripotent stem cell reprogramming of cryopreserved lymphoblastoid cell lines. J Biol Methods. 2020;7:e124 pubmed publisher |
Sharipova D, Kovalenko V, Bairamova E, Vartanova V, Grigor eva E, Vyatkin Y, et al. Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease. Stem Cell Res. 2019;41:101652 pubmed publisher |
Dementyeva E, Medvedev S, Kovalenko V, Vyatkin Y, Kretov E, Slotvitsky M, et al. Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy. Biochemistry (Mosc). 2019;84:291-298 pubmed publisher |
Haghighi F, Dahlmann J, Nakhaei Rad S, Lang A, Kutschka I, Zenker M, et al. bFGF-mediated pluripotency maintenance in human induced pluripotent stem cells is associated with NRAS-MAPK signaling. Cell Commun Signal. 2018;16:96 pubmed publisher |
Lu H, Leong M, Lim T, Chua Y, Lim J, Du C, et al. Engineering a functional three-dimensional human cardiac tissue model for drug toxicity screening. Biofabrication. 2017;9:025011 pubmed publisher |
Ahmadian Baghbaderani B, Tian X, Scotty Cadet J, Shah K, Walde A, Tran H, et al. A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells. PLoS ONE. 2016;11:e0161229 pubmed publisher |
Drozd A, Walczak M, Piaskowski S, Stoczyńska Fidelus E, Rieske P, Grzela D. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system. Stem Cell Res Ther. 2015;6:122 pubmed publisher |
Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2013;31:458-66 pubmed publisher |
